Glucagon receptor gene deletion in insulin knockout mice modestly reduces blood glucose and ketones but does not promote survival

Ursula H. Neumann, Jessica S S Ho, Majid Mojibian, Scott D. Covey, Maureen J. Charron, Timothy J. Kieffer

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

Objective It has been thought that the depletion of insulin is responsible for the catabolic consequences of diabetes; however, evidence suggests that glucagon also plays a role in diabetes pathogenesis. Glucagon suppression by glucagon receptor (Gcgr) gene deletion, glucagon immunoneutralization, or Gcgr antagonist can reverse or prevent type 1 diabetes in rodents suggesting that dysregulated glucagon is also required for development of diabetic symptoms. However, the models used in these studies were rendered diabetic by chemical- or immune-mediated β-cell destruction, in which insulin depletion is incomplete. Therefore, it is unclear whether glucagon suppression could overcome the consequence of the complete lack of insulin. Methods To directly test this we characterized mice that lack the Gcgr and both insulin genes (GcgrKO/InsKO). Results In both P1 pups and mice that were kept alive to young adulthood using insulin therapy, blood glucose and plasma ketones were modestly normalized; however, mice survived for only up to 6 days, similar to GcgrHet/InsKO controls. In addition, Gcgr gene deletion was unable to normalize plasma leptin levels, triglycerides, fatty acids, or hepatic cholesterol accumulation compared to GcgrHet/InsKO controls. Conclusion Therefore, the metabolic manifestations associated with a complete lack of insulin cannot be overcome by glucagon receptor gene inactivation.

Original languageEnglish (US)
Pages (from-to)731-736
Number of pages6
JournalMolecular Metabolism
Volume5
Issue number8
DOIs
StatePublished - Aug 1 2016

Fingerprint

Glucagon Receptors
Gene Deletion
Ketones
Knockout Mice
Blood Glucose
Glucagon
Insulin
Gene Silencing
Leptin
Type 1 Diabetes Mellitus
Rodentia
Triglycerides
Fatty Acids
Cholesterol
Liver
Genes

Keywords

  • Glucagon
  • Glucose metabolism
  • Insulin
  • Lipid metabolism
  • Mice
  • Type 1 diabetes

ASJC Scopus subject areas

  • Molecular Biology
  • Cell Biology

Cite this

Glucagon receptor gene deletion in insulin knockout mice modestly reduces blood glucose and ketones but does not promote survival. / Neumann, Ursula H.; Ho, Jessica S S; Mojibian, Majid; Covey, Scott D.; Charron, Maureen J.; Kieffer, Timothy J.

In: Molecular Metabolism, Vol. 5, No. 8, 01.08.2016, p. 731-736.

Research output: Contribution to journalArticle

Neumann, Ursula H. ; Ho, Jessica S S ; Mojibian, Majid ; Covey, Scott D. ; Charron, Maureen J. ; Kieffer, Timothy J. / Glucagon receptor gene deletion in insulin knockout mice modestly reduces blood glucose and ketones but does not promote survival. In: Molecular Metabolism. 2016 ; Vol. 5, No. 8. pp. 731-736.
@article{119a33d91b824e1891255a4a737b79a9,
title = "Glucagon receptor gene deletion in insulin knockout mice modestly reduces blood glucose and ketones but does not promote survival",
abstract = "Objective It has been thought that the depletion of insulin is responsible for the catabolic consequences of diabetes; however, evidence suggests that glucagon also plays a role in diabetes pathogenesis. Glucagon suppression by glucagon receptor (Gcgr) gene deletion, glucagon immunoneutralization, or Gcgr antagonist can reverse or prevent type 1 diabetes in rodents suggesting that dysregulated glucagon is also required for development of diabetic symptoms. However, the models used in these studies were rendered diabetic by chemical- or immune-mediated β-cell destruction, in which insulin depletion is incomplete. Therefore, it is unclear whether glucagon suppression could overcome the consequence of the complete lack of insulin. Methods To directly test this we characterized mice that lack the Gcgr and both insulin genes (GcgrKO/InsKO). Results In both P1 pups and mice that were kept alive to young adulthood using insulin therapy, blood glucose and plasma ketones were modestly normalized; however, mice survived for only up to 6 days, similar to GcgrHet/InsKO controls. In addition, Gcgr gene deletion was unable to normalize plasma leptin levels, triglycerides, fatty acids, or hepatic cholesterol accumulation compared to GcgrHet/InsKO controls. Conclusion Therefore, the metabolic manifestations associated with a complete lack of insulin cannot be overcome by glucagon receptor gene inactivation.",
keywords = "Glucagon, Glucose metabolism, Insulin, Lipid metabolism, Mice, Type 1 diabetes",
author = "Neumann, {Ursula H.} and Ho, {Jessica S S} and Majid Mojibian and Covey, {Scott D.} and Charron, {Maureen J.} and Kieffer, {Timothy J.}",
year = "2016",
month = "8",
day = "1",
doi = "10.1016/j.molmet.2016.05.014",
language = "English (US)",
volume = "5",
pages = "731--736",
journal = "Molecular Metabolism",
issn = "2212-8778",
publisher = "Elsevier GmbH",
number = "8",

}

TY - JOUR

T1 - Glucagon receptor gene deletion in insulin knockout mice modestly reduces blood glucose and ketones but does not promote survival

AU - Neumann, Ursula H.

AU - Ho, Jessica S S

AU - Mojibian, Majid

AU - Covey, Scott D.

AU - Charron, Maureen J.

AU - Kieffer, Timothy J.

PY - 2016/8/1

Y1 - 2016/8/1

N2 - Objective It has been thought that the depletion of insulin is responsible for the catabolic consequences of diabetes; however, evidence suggests that glucagon also plays a role in diabetes pathogenesis. Glucagon suppression by glucagon receptor (Gcgr) gene deletion, glucagon immunoneutralization, or Gcgr antagonist can reverse or prevent type 1 diabetes in rodents suggesting that dysregulated glucagon is also required for development of diabetic symptoms. However, the models used in these studies were rendered diabetic by chemical- or immune-mediated β-cell destruction, in which insulin depletion is incomplete. Therefore, it is unclear whether glucagon suppression could overcome the consequence of the complete lack of insulin. Methods To directly test this we characterized mice that lack the Gcgr and both insulin genes (GcgrKO/InsKO). Results In both P1 pups and mice that were kept alive to young adulthood using insulin therapy, blood glucose and plasma ketones were modestly normalized; however, mice survived for only up to 6 days, similar to GcgrHet/InsKO controls. In addition, Gcgr gene deletion was unable to normalize plasma leptin levels, triglycerides, fatty acids, or hepatic cholesterol accumulation compared to GcgrHet/InsKO controls. Conclusion Therefore, the metabolic manifestations associated with a complete lack of insulin cannot be overcome by glucagon receptor gene inactivation.

AB - Objective It has been thought that the depletion of insulin is responsible for the catabolic consequences of diabetes; however, evidence suggests that glucagon also plays a role in diabetes pathogenesis. Glucagon suppression by glucagon receptor (Gcgr) gene deletion, glucagon immunoneutralization, or Gcgr antagonist can reverse or prevent type 1 diabetes in rodents suggesting that dysregulated glucagon is also required for development of diabetic symptoms. However, the models used in these studies were rendered diabetic by chemical- or immune-mediated β-cell destruction, in which insulin depletion is incomplete. Therefore, it is unclear whether glucagon suppression could overcome the consequence of the complete lack of insulin. Methods To directly test this we characterized mice that lack the Gcgr and both insulin genes (GcgrKO/InsKO). Results In both P1 pups and mice that were kept alive to young adulthood using insulin therapy, blood glucose and plasma ketones were modestly normalized; however, mice survived for only up to 6 days, similar to GcgrHet/InsKO controls. In addition, Gcgr gene deletion was unable to normalize plasma leptin levels, triglycerides, fatty acids, or hepatic cholesterol accumulation compared to GcgrHet/InsKO controls. Conclusion Therefore, the metabolic manifestations associated with a complete lack of insulin cannot be overcome by glucagon receptor gene inactivation.

KW - Glucagon

KW - Glucose metabolism

KW - Insulin

KW - Lipid metabolism

KW - Mice

KW - Type 1 diabetes

UR - http://www.scopus.com/inward/record.url?scp=84989935619&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84989935619&partnerID=8YFLogxK

U2 - 10.1016/j.molmet.2016.05.014

DO - 10.1016/j.molmet.2016.05.014

M3 - Article

VL - 5

SP - 731

EP - 736

JO - Molecular Metabolism

JF - Molecular Metabolism

SN - 2212-8778

IS - 8

ER -